Twist Bioscience Corporation Operating Expenses
Twist Bioscience Corporation (TWST) reported Operating Expenses of $34.39 million for the 3-month period ending 2018-12-31, per its 10-Q filed 2019-02-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-02-11
- Twist Bioscience Corporation operating expenses for the quarter ending 2018-12-31 was $34.39M, a 63.26% increase year-over-year.
- Twist Bioscience Corporation operating expenses for the quarter ending 2017-12-31 was $21.06M.
| Period end | Operating Expenses 3 month |
|---|---|
| 2018-12-31 | $34.39M 10-Q · filed 2019-02-11 |
| 2017-12-31 | $21.06M 10-Q · filed 2019-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |